The chinese love powder made from endangered animals and trash plants , americans love their superfoods. A plant called alfalfa (luzerne) that french farmers love to grow because it can get Nitrogen itself and it's cheap and packed with protein, they feed it to cattle, so to cows and also americans. Americans actually pay a high price to get supercheap leaves in...
Weekly chart outlook for the long term. I see some upside in the near future . Lets see how this plays out. Mainly publishing to come back and study the price action.
FHTX could go for a run after this consolidation. Last time it consolidated for 14 days. We are only on day 8 currently, but it could break higher at anytime. Looks like it ran out of sellers. Could be a good run if it breaks out of this consolidation box.
CXRXF has been consolidating for a long time but now presents a low risk buy in. Notice the two trend lines, we are currently at the lower one. It could drop back 10% but I suspect even if it does, it will eventually drift towards the upper trend line. That's a nice 46% gain from here. Who knows, if it breaks the upper line it could really run.
People have written obituaries about this stock, as it is not moving since March 2020. Stock has also closed below its 200 ema on a daily chart (which is generally considered bearish sign) I may be wrong here, but what i see is stock is nicely moving in flag formation on a weekly chart. It is consolidating for now. I will enter once that level breaks.
Here we have a low float stock that recently popped past the all time Resistance channel from back in 2016. Their is currently a massive order sitting to purchase 200k shares within the current price squeeze (triangle formation) Lots of good news about this stock recently. I like this setup and I personally think it will explode! Hodl
Very little to be found on this one fundamentally, as to what the catalyst could be. But SEC forms show numerous insiders (including CEO) buying before Christmas. Today, analyst Geulah Livshits from Chardan Capital released a buy rating with a PT of 33.
Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules. According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30,...
Timestamp (black vertical line) : Mar 1 2020 ---> Lockdowns worldwide due to Covid-19 - - - - - - - - - - - - - - - - - - - - - - - - - - - GlaxoSmithKline plc ( GSK ) LSE:GSK GlaxoSmithKline plc ( GSK ) is a British multinational pharmaceutical company headquartered in Brentford, England. Price decrease of 9.50% - - - - - - - - - - - - - - - - - - - - - - -...
Timestamp (black vertical line) : Mar 1 2020 ---> Lockdowns worldwide due to Covid-19 - - - - - - - - - - - - - - - - - - - - - - - - - - - GlaxoSmithKline plc (GSK) LSE:GSK GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England. Price decrease of 9.50% - - - - - - - - - - - - - - - - - - - - -...
Not much history on this stock but with more potential lockdowns telemedicine seems like a buy to me. Testing my luck on this one. We have to at least bounce off support If it reaches $49-50 then we would have a cup and handle and target of $60-65 is possible. However, nothing on this chart screams BUY to me. Sometimes you have to make dumb decisions to get dumb...
BUY CALL FOR BSE:ANUHPHR for short term target - 218 expected profit - 50%
Cipla is showing negative divergences on a 15 minutes time frame. Ideally, when price makes a new high and RSI fails to make a new high, it gives a good signal for a short term pullback. However, pharma is in a strong bull rally, so entry and exit should be real quick. Target 1 - 810 target 2 - 795
Sun pharma is the biggest contributor in the Indian Pharma Index. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again. Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point. It completed its corrective wave (2) at 450 levels around September. It is all set to...
NSE:SUNPHARMA Disclaimer: I am not SEBI registered person please contact your financial advisor before any investment decision.